National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 4) (PB 32 of 2018) (Cth)

PB 32 of 2018

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 4)

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 27 April 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

Amendment instrument – Pharmaceutical benefits – early supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 4)

(2)This Instrument may also be cited as PB 32 of 2018.

2          Commencement

This Instrument commences on 1 May 2018.

3          Amendment of PB 120 of 2015

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1        Amendments

1. Schedule 1, after entry for Balsalazide in the form Capsule containing balsalazide sodium 750 mg

insert:

Balsalazide Capsule containing balsalazide sodium 750 mg 20 280 5

1. Schedule 1, after entry for Brexpiprazole in the form Tablet 4 mg

insert:

Brivaracetam	Oral solution 10 mg per mL, 300 mL	20	1	5
Brivaracetam	Tablet 25 mg	20	56	5
Brivaracetam	Tablet 50 mg	20	56	5
Brivaracetam	Tablet 75 mg	20	56	5
Brivaracetam	Tablet 100 mg	20	56	5

1. Schedule 1

omit:

Flutamide Tablet 250 mg, 30 20 3 5

1. Schedule 1

omit:

Risedronic acid and calcium with colecalciferol Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g with colecalciferol 22 micrograms 20 1 5